LYY5:F:F-Mullti Units France - Lyxor MSCI Europe (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 197.58

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-9.54 (-1.70%)

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.36 (-0.71%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.60 (-1.07%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.29 (-1.90%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

+1.88 (+1.93%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 41.48B
0ZC:F Zscaler Inc

+5.10 (+2.81%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing LYY5:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.38% 82% B 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.38% 82% B 72% C
Trailing 12 Months  
Capital Gain 8.62% 73% C 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.62% 70% C- 56% F
Trailing 5 Years  
Capital Gain 93.25% 68% D+ 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 93.25% 68% D+ 48% F
Average Annual (5 Year Horizon)  
Capital Gain 11.91% 75% C 68% D+
Dividend Return 11.91% 72% C 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.33% 60% D- 88% B+
Risk Adjusted Return 105.12% 92% A 94% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike